PolyPid receives $4.3 million FDA fee waiver for drug application

March 17, 2026 8:30 AM

PolyPid Ltd. (NASDAQ: PYPD) announced that the U.S. Food and Drug Administration has granted a small business waiver of the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found